登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CA125】

CA125信息

英文名称:Mucin-16
中文名称:粘蛋白-16
靶点别称:Mucin-16 Short Isoform,Mucin-16 Long Isoform,Ovarian carcinoma antigen CA125,Ovarian cancer-related tumor marker CA125,MUC16,MUC-16,CA-125,Mucin 16, Cell Surface Associated,CA125,CA125 Ovarian Cancer Antigen,Mucin-16,CA-125 Antigen,FLJ14303
上市药物数量:0
临床药物数量:6
最高研发阶段:临床三期

CA125产品列表

ACRO质量管理体系
 
评论(3)
CA5-H82F4|Biotinylated Human CA125 / MUC16 Protein, Fc,Avitag™
  1. 139XXXXXXX3
  2. 2人赞
  3. 该产品纯度很高,我们用于酶联免疫吸附实验,试验结果很好,产品性能稳定,储存时期长,质量可靠,对于我们的项目进度帮助大
  4. 2022-12-16
CA5-H82F4|Biotinylated Human CA125 / MUC16 Protein, Fc,Avitag™
  1. 135XXXXXXX2
  2. 0人赞
  3. 用于ELISA实验,蛋白表达稳定,无污染,背景值低,信号放大明显,包被结合能力强,冷冻保存也能完美表达,十分推荐此款抗原
  4. 2024-06-21
CA5-H52H6|Human CA125 / MUC16 (13810-14451) Protein, His Tag (MALS verified)
  1. 188XXXXXXX2
  2. 0人赞
  3. 使用蛋白进行Elisa实验,用于化合物的筛选,结果稳定,蛋白活性高,实验进展很顺利,对比其他厂家蛋白活性更高哦,
  4. 2024-02-19
 

CA125分子别名

CA125,CA-125,CA125MUC-16,FLJ14303,MUC16,mucin 16,mucin-16

CA125分子背景

The CA125, also known as the MUC16, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy. The CA 125 molecule is almost certainly a glycoprotein with a predominance of O-linkages. It is heterogeneous with regard to both size and charge, most likely due to continuous deglycosylation of side chains during its life-span in bodily fluids. It exists as a very large complex (perhaps as much as 4 million daltons) under natural conditions.

CA125临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Oregovomab B43.13 临床三期 Paladin Pharma 卵巢癌, 转移性上皮癌, 腹部肿瘤, 卵巢上皮癌, 胰腺癌, 肿瘤, 腹膜癌, 输卵管癌, 腺癌 详情
LBL-033 LBL-033 临床二期 南京维立志博生物科技有限公司 肿瘤 详情
REGN-5668 REGN-5668 临床二期 卵巢癌, 腹膜癌, 子宫内膜癌, 输卵管癌 详情
Ubamatamab REGN-4018 临床二期 卵巢癌, 腹膜癌, 子宫内膜癌, 输卵管癌 详情
PRGN-3005 PRGN-3005 临床一期 Precigen Inc 卵巢癌, 食道癌, 肉瘤, 腹膜癌, 非霍奇金淋巴瘤, 输卵管癌, 宫颈癌 详情
JCAR-020 JCAR-020 临床一期 Memorial Sloan Kettering Cancer Center, Juno Therapeutics Inc, Eureka Therapeutics Inc 实体瘤, 肿瘤 详情
huAR9.6-IRDye800 University Of Nebraska Medical Center 详情

消息提示

请输入您的联系方式,再点击提交!

确定